Abivax SA

ABVX · Healthcare

$113.67

Capitalizzazione: 9.92B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Abivax SA? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

GlobeNewswire1 set 2026, 11:00

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Business Wire4 ago 2026, 07:00

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer

GlobeNewswire30 lug 2026, 20:05

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

Simply Wall St.26 lug 2026, 08:07

ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?

MT Newswires24 lug 2026, 09:47

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating